Information Provided By:
Fly News Breaks for November 11, 2015
DEPO
Nov 11, 2015 | 14:05 EDT
Roth Capital raised Depomed's price target to $24 following the Q3 report and reiterated its Buy rating. The firm said fundamentals are moderately higher than our prior forecasts and raised outer year earnings targets by 10c per year.
News For DEPO From the Last 2 Days
There are no results for your query DEPO